Wikipedia -WSS

Wikipedia

author：focus 2025-09-29 21:02:19 - browse：849

Stacks of silver coins surrounded by a medicare health insurance card — insurance coverage from STAT — A federal rule that could make Medicare reimbursement for breakthrough devices easier is slated for early summer. Adobe

WASHINGTON — A federal rule aiming to make reimbursement for breakthrough devices easier is slated for early summer, a Centers for Medicare and Medicaid Services official said on Thursday.

The agency has faced intense pressure from device makers frustrated with the slow pace of Medicare reimbursement decisions. Medical technology lobby AdvaMed sent CMS a strongly-worded letter in March asking why it has taken so long to get the breakthrough device program moving.

Dora Hughes, director of the clinical standards center at CMS, told attendees at the Medical Device Manufacturers’ Association conference the agency wanted to take the time to meaningfully address feedback sent during the comment period, which closed in August. She also noted the organization’s goal of releasing the final rule with a slate of other policies, including a rule clarifying the agency’s thinking on what kind of evidence would be needed to convince the agency that a given device is both reasonable and necessary.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Supreme Court to hear if Covid misinformation is protected speech

hotspot

WSS

ALS treatment from Biogen, Ionis fails in study

Asbestos ban is immediate, but health effects will linger for decades

Texas board proposes rules on abortion law emergency exemption

Obesity drug from Roche shows promise in early study

Steward Health Care expansion into Malta flopped

Galapagos to make CAR

explore

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

In age of alternative facts, a scholarly course on calling out crap

CVS is willing to dump 10% of its Medicare Advantage members

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Cancer, immunology, HIV research ensnared in fetal tissue politics

Psychedelics group wrestles with new pharma identity

Lilly’s weekly insulin works as well as daily products, new studies show

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Medical devices makers are asking for forgiveness, not permission

BioMarin wins approval for gene therapy to treat hemophilia A

Diabetes management: Digital health tools fall short, study says

focus

Medicare Advantage insurers pressure Biden for bigger payments

Lilly’s weekly insulin works as well as daily products, new studies show

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Readout LOUD podcast, live from the STAT Breakthrough Summit East

focus

hotspot

entertainment

focus